サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519485

バイオテクノロジー市場レポート：製品タイプ、技術、用途、地域別、2024～2032年

Biotechnology Market Report by Product Type, Technology, Application, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 136 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.12円
バイオテクノロジー市場レポート：製品タイプ、技術、用途、地域別、2024～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオテクノロジー市場規模は2023年に7,149億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけて6.53%の成長率（CAGR）を示し、2032年までに1兆2,772億米ドルに達すると予測しています。個別化医療の研究開発（R&D）の増加、遺伝子工学の数多くの進歩、サステイナブル農業への需要の高まりなどが、市場を後押しする主要要因となっています。

バイオテクノロジーとは、革新的な製品や技術を開発するために生物、細胞、生物システムを利用する学際的なセグメントです。分子・細胞レベルでの生物学的プロセスや生物を利用し、医療、農業、環境管理など、産業界全体のさまざまな課題に対処することが含まれます。バイオテクノロジーには、遺伝子工学、バイオ医薬品、バイオインフォマティクス、合成生物学などのセグメントが含まれ、これらはすべて、新たなソリューションの創造、既存のプロセスの改善、生命システムの理解の向上を目的としています。このセグメントは、現代医療の形成、サステイナブル農業、多様な用途のための新材料の開発において重要な役割を果たしています。

遺伝子研究と分子生物学の理解の急速な進歩により、遺伝子編集、個別化医療、新規治療などのセグメントで技術革新が進んでいることが、予測期間中の市場成長を刺激すると考えられます。さらに、慢性疾患の有病率の増加と標的治療の必要性が、バイオ医薬品と精密医療に対する需要を増大させており、市場成長にプラスの影響を与えています。さらに、世界人口の増加と限られた耕地面積に起因するサステイナブル農業ソリューションに対する需要の高まりが、作物改良と生物農薬におけるバイオテクノロジー技術の採用を加速させています。これとは別に、バイオテクノロジーとバイオインフォマティクスとして知られる情報技術の融合が、研究開発のためのデータ駆動型洞察を強化し、市場の成長を促進しています。さらに、環境の持続可能性への注目の高まりによるバイオレメディエーション手法やバイオ燃料の市場開拓が、市場の成長に寄与しています。

バイオテクノロジー市場傾向/促進要因：

遺伝子工学の急速な進歩

画期的なCRISPR-Cas9技術に代表される遺伝子工学の著しい進歩は、バイオテクノロジー市場の主要な促進要因です。この技術は、科学者が生物内の遺伝子を正確に改変することを可能にし、医療、農業、工業プロセスへの応用に前例のない可能性を提示します。医療では、遺伝子工学は遺伝性疾患やがんに対する革新的な遺伝子治療の開発を促進し、個別化治療の有望な道を記載しています。さらに、インスリンや酵素のような貴重な化合物の生産のために微生物を工学的に改良する能力は、製薬と工業製造に変革をもたらしました。

個別化医療と治療に対する需要の増加

個人の遺伝的体質に合わせた個別化医療の概念は、バイオテクノロジー市場で支持を集めています。ゲノム配列解析技術の進歩により、個人の遺伝暗号を解析し、疾患に関連する遺伝的変異を特定することが可能になりました。これにより、患者固有の遺伝的特徴に対応する標的治療が開発され、治療効果が向上し、副作用が軽減されるようになりました。バイオテクノロジーは、モノクローナル抗体や遺伝子治療などのバイオ医薬品の製造を可能にし、個別化医療の原則に合致しています。さらに、遺伝子マーカー別の診断により、疾病の早期発見と予後予測が可能になり、医療はより正確で個別化されたアプローチへと再構築されます。

サステイナブル農業ソリューションへのニーズの高まり

世界の食糧需要の増大は、環境問題やサステイナブル農業慣行の必要性と相まって、農業におけるバイオテクノロジーソリューションの採用を後押ししています。収量、害虫抵抗性、栄養成分の強化を目的に遺伝子組み換えされた作物（GMO）は、バイオテクノロジーが農業に及ぼす影響の一例です。自然界に存在する生物に由来する生物農薬は、環境への影響が少ないことから、従来の化学農薬よりも好まれるようになってきています。バイオテクノロジーは、植物の形質を最適化し、気候変動に対する作物の回復力を向上させ、栄養効率を高めるツールを提供し、食糧安全保障と資源の持続可能性に貢献します。この原動力は、エコロジカル・フットプリントを最小限に抑えながら農業セクターの差し迫った課題に取り組むバイオテクノロジーの重要な役割を反映しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブ概要

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオテクノロジー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 機器
  • 試薬
  • ソフトウェアとサービス

第7章 市場内訳：技術別

  • ナノバイオテクノロジー
  • 組織工学と再生
  • DNA配列解析
  • 細胞ベースのアッセイ
  • 発酵
  • PCR技術
  • クロマトグラフィー
  • その他

第8章 市場内訳：用途別

  • 医療
  • 食料と農業
  • 天然資源と環境
  • 工業処理
  • バイオインフォマティクス
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Amgen Inc.
    • Biocon Limited
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • Genmab A/S
    • Lonza Group AG
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Seagen Inc.
    • Syngenta AG
    • Vertex Pharmaceuticals Incorporated
図表

List of Figures

  • Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: North America: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: United States: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Canada: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: China: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Japan: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: India: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: South Korea: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Australia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Germany: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: France: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Italy: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Spain: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Russia: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Latin America: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Brazil: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Mexico: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2023
  • Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Biotechnology Industry: SWOT Analysis
  • Figure 92: Global: Biotechnology Industry: Value Chain Analysis
  • Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Biotechnology Market: Competitive Structure
  • Table 7: Global: Biotechnology Market: Key Players
目次
Product Code: SR112024A5785

The global biotechnology market size reached US$ 714.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,277.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.53% during 2024-2032. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.

The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biotechnology market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, technology, and application.

Breakup by Product Type:

Instruments

Reagents

Software and Services

The report has provided a detailed breakup and analysis of the market based on the product type. This includes instruments, reagents, and software and services.

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

Nanobiotechnology

Tissue Engineering and Regeneration

DNA Sequencing

Cell-Based Assays

Fermentation

PCR Technology

Chromatography

Others

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others.

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

Healthcare

Food and Agriculture

Natural Resources and Environment

Industrial Processing

Bioinformatics

Others

Healthcare dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes healthcare, food and agriculture, natural resources and environment, industrial processing, bioinformatics, and others. According to the report, healthcare represented the largest segment.

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amgen Inc.

Biocon Limited

Biogen Inc.

F. Hoffmann-La Roche AG

Genmab A/S

Lonza Group AG

Novartis AG

Novo Nordisk A/S

Pfizer Inc.

Regeneron Pharmaceuticals Inc.

Seagen Inc.

Syngenta AG

Vertex Pharmaceuticals Incorporated

Recent Developments:

In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.

In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.

In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.

Key Questions Answered in This Report

  • 1. How big is the global biotechnology market?
  • 2. What is the expected growth rate of the global biotechnology market during 2024-2032?
  • 3. What are the key factors driving the global biotechnology market?
  • 4. What has been the impact of COVID-19 on the global biotechnology market?
  • 5. What is the breakup of the global biotechnology market based on the application?
  • 6. What are the key regions in the global biotechnology market?
  • 7. Who are the key players/companies in the global biotechnology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Nanobiotechnology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Engineering and Regeneration
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cell-Based Assays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fermentation
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 PCR Technology
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Chromatography
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Food and Agriculture
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Natural Resources and Environment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Industrial Processing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Bioinformatics
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Biocon Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genmab A/S
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novo Nordisk A/S
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Regeneron Pharmaceuticals Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Seagen Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Syngenta AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis
    • 14.3.13 Vertex Pharmaceuticals Incorporated
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis